FileMood

Download Encyclopedia of Biopharmaceutical Statistics 2nd Ed. - (Malestrom)

Encyclopedia of Biopharmaceutical Statistics 2nd Ed Malestrom

Name

Encyclopedia of Biopharmaceutical Statistics 2nd Ed. - (Malestrom)

 DOWNLOAD Copy Link

Total Size

65.0 MB

Total Files

197

Hash

F803B1EBA1BB0EA77E4B8EFAC10206ECEAD270CF

/Ac-As/

Acceptance Sampling.pdf

437.2 KB

Active Control Trials.pdf

311.0 KB

Adaptive Designs.pdf

126.3 KB

Adaptive Dose-Finding Based on Efficacy-Toxicity Trade-Offs .pdf

154.7 KB

Adjustment for Covariates.pdf

173.5 KB

Adverse Event Reporting.pdf

286.9 KB

Alpha Spending Function.pdf

109.3 KB

Ames Test.pdf

415.8 KB

Analysis of 2 K Tables .pdf

140.1 KB

Analysis of Clustered Binary Data.pdf

104.8 KB

Analysis of Heritability.pdf

269.8 KB

Analysis of Repeated Measures Data with Missing Values- An Overview of Methods .pdf

102.2 KB

Analysis of Variance.pdf

1.7 MB

ANCOVA Approach for Premarketing Shelf Life Determination with Multiple Factors .pdf

74.1 KB

Assay Development.pdf

434.2 KB

Assay Validation.pdf

430.2 KB

/Ba-Ca to Ce-Cu/

Bayesian Methods in Meta-Analysis.pdf

100.8 KB

Bayesian Statistics.pdf

345.9 KB

Bayesian Two-Stage Design for Phase II Clinical Trials.pdf

154.3 KB

Bioassay.pdf

149.0 KB

Bioavailability and Bioequivalence.pdf

261.2 KB

Bioinformatics.pdf

136.8 KB

Biologics.pdf

438.3 KB

Biopharmaceutics.pdf

1.1 MB

Blinding.pdf

278.0 KB

Bootstrap, The.pdf

271.4 KB

Bracketing Design.pdf

61.9 KB

Bridging Studies.pdf

218.8 KB

Calibration.pdf

345.0 KB

Canadian Health Products and Food Branch (HPFB) and Therapeutic Products Directorate (TPD).pdf

233.2 KB

Cancer Trials.pdf

332.0 KB

Carcinogenicity Studies of Pharmaceuticals.pdf

518.1 KB

Carry-Forward Analysis.pdf

258.3 KB

Case-Control Studies, Inference in.pdf

205.5 KB

Center Weighting in Multicenter Trials.pdf

121.0 KB

Clinical Data Management.pdf

803.7 KB

Clinical Endpoint.pdf

170.4 KB

Clinical Pharmacology.pdf

134.8 KB

Clinical Trial Process.pdf

169.0 KB

Clinical Trial Simulation.pdf

103.8 KB

Clinical Trial Simulations for Earlier Development Phases.pdf

90.7 KB

Clinical Trial Simulations for Later Development Phases.pdf

126.5 KB

Clinical Trials.pdf

126.5 KB

Cluster Trials.pdf

177.3 KB

Clustered Study Designs- Power Analysis.pdf

265.5 KB

Combination Drug Clinical Trial.pdf

173.0 KB

Comparing Variabilities in Clinical Research.pdf

696.9 KB

Confidence Interval and Hypothesis Testing.pdf

192.0 KB

Confounding and Interaction.pdf

290.8 KB

Content Uniformity.pdf

203.4 KB

Contract Research Organization (CRO).pdf

209.9 KB

Correlated Probit Model.pdf

118.6 KB

Cost-Effectiveness Analysis.pdf

253.1 KB

Crossover Design.pdf

331.2 KB

Cutoff Designs.pdf

337.9 KB

/Da-Fa to Fo-In/

Data Mining and Biopharmaceutical Research.pdf

472.5 KB

Data Monitoring Committees (DMC).pdf

435.8 KB

Diagnostic Imaging.pdf

376.4 KB

Dose Proportionality.pdf

491.2 KB

Dose Response Analysis in Clinical Trials.pdf

251.6 KB

Dose Response Study Design.pdf

335.2 KB

Dropout.pdf

256.7 KB

Drug Development.pdf

302.1 KB

Ecologic Inference.pdf

184.3 KB

ED50-ED90.pdf

692.7 KB

Enrichment Design.pdf

141.4 KB

Equivalence Trials.pdf

257.3 KB

Ethnic Factors.pdf

135.2 KB

Expiration Dating Period.pdf

312.0 KB

Exploratory Factor Analysis.pdf

616.6 KB

Extra Variation Models.pdf

947.2 KB

Factor Analysis.pdf

88.2 KB

Factorial Designs.pdf

756.1 KB

Failure-Time Model.pdf

159.1 KB

False Discovery Rate (FDR).pdf

317.9 KB

Food and Drug Administration.pdf

310.2 KB

Generalizability Probability in Clinical Research.pdf

183.0 KB

Generalized Estimating Equation.pdf

183.0 KB

Generalized Estimating Equations (GEE) Method- Sample Size Estimation.pdf

94.3 KB

Genetic Linkage and Linkage Disequilibrium Analysis.pdf

361.7 KB

Global Database and System.pdf

327.5 KB

Good Clinical Practice.pdf

283.5 KB

Good Programming Practice.pdf

281.9 KB

Good Statistics Practice.pdf

244.3 KB

Group Sequential Methods.pdf

422.9 KB

Group Sequential Tests and Variance Heterogeneity in Clinical Trials.pdf

109.2 KB

Hypotheses and False Positive Rate in Active Control Non-Inferiority Trials.pdf

309.7 KB

Imputation in Clinical Research.pdf

181.7 KB

Imputation with Item Nonrespondents.pdf

263.9 KB

In Vitro Bioequivalence Testing.pdf

307.3 KB

In Vitro Dissolution Profile Comparison.pdf

307.3 KB

In Vitro Micronucleus Test.pdf

621.3 KB

Individual Bioequivalence.pdf

341.1 KB

Instrument Development and Validation.pdf

446.0 KB

Integrated Summary Report.pdf

523.7 KB

Intention-to-Treat Analyses (ITT).pdf

175.9 KB

Interactive Voice Randomization System (IVRS).pdf

665.2 KB

Interim Analysis.pdf

574.2 KB

International Conference on Harmonization (ICH).pdf

165.6 KB

Investigating Quality-of-Life in Clinical Trials.pdf

475.7 KB

/Ka-Mu/

Coefficients in Medical Research.pdf

145.2 KB

Kaplan-Meier Estimator.pdf

603.9 KB

Kullback-Leibler Divergence for Evaluating Equivalence.pdf

235.8 KB

Laboratory Analyses.pdf

321.3 KB

Latent Class Analysis.pdf

159.6 KB

Lilly Reference Ranges.pdf

577.0 KB

Local Influence Analysis.pdf

78.1 KB

Logistic Regression in Three-Point Designs.pdf

149.4 KB

Logistic Regression.pdf

897.7 KB

Maximum Tolerable Dose for Cancer Chemotherapy.pdf

358.9 KB

McNemar's Test.pdf

87.1 KB

Measuring Agreement.pdf

465.5 KB

MedDRA and Its Impact on Pharmaceutical Development.pdf

278.6 KB

Medical Devices.pdf

479.4 KB

Meta-Analysis of Therapeutic Trials.pdf

591.6 KB

Microarray Gene Expression.pdf

1.2 MB

Minimization Procedure.pdf

215.5 KB

Minimum Effective Dose.pdf

215.5 KB

Ministry of Health, Labour and Welfare and Pharmaceutical Administration in Japan.pdf

610.4 KB

Missing Values in Repeated Measurement Designs.pdf

130.8 KB

Mixed Effects Models.pdf

222.8 KB

Modified Large Sample Method.pdf

341.4 KB

Multicenter Trials.pdf

176.2 KB

Multicollinearity.pdf

153.0 KB

Multinational Clinical Trial.pdf

316.4 KB

/No-Pr/

Noninferiority Analysis in Active Controlled Clinical Trials.pdf

179.1 KB

Odds Ratio.pdf

300.2 KB

Onset of Action.pdf

122.8 KB

Ordered Multiple Class Receiver Operating Characteristic (ROC) Analysis.pdf

142.5 KB

Outlier Detection in Clinical Research.pdf

572.0 KB

P-Values, Evidence and Multiplicity Considerations for Controlled Clinical Trials.pdf

461.1 KB

P-Values.pdf

550.6 KB

Parallel Design.pdf

220.9 KB

Patient Compliance.pdf

251.6 KB

Percentile Charts on Correlated Measures.pdf

181.4 KB

Pharmacodynamic Issues.pdf

357.1 KB

Pharmacodynamics with Covariates.pdf

536.8 KB

Pharmacodynamics with No Covariates.pdf

380.2 KB

Pharmacoeconomics.pdf

1.0 MB

Phase I Cancer Clinical Trials.pdf

343.0 KB

Placebo Effect.pdf

221.3 KB

Population Bioequivalence.pdf

311.5 KB

Population PK-PD Analysis.pdf

251.0 KB

Postmarketing Adverse Drug Event Signaling.pdf

633.7 KB

Postmarketing Surveillance.pdf

336.5 KB

Power.pdf

106.3 KB

Prediction Trees.pdf

189.0 KB

Principal Component Analysis.pdf

128.3 KB

Process Validation.pdf

1.0 MB

Profile Analysis.pdf

217.6 KB

Proportion of Treatment Effect.pdf

89.2 KB

Proportional Hazards Regression Model.pdf

352.0 KB

Protocol Development.pdf

173.0 KB

/Qt-St to Su-Zs/

QT Analysis.pdf

174.5 KB

Randomization.pdf

227.0 KB

Rank Regression in Stability Analysis.pdf

224.2 KB

Release Targets.pdf

274.0 KB

Reliability.pdf

300.2 KB

Reproducibility Probability in Clinical Research.pdf

486.0 KB

Reproductive-Developmental Studies.pdf

350.4 KB

Response Surface Methodology.pdf

1.0 MB

Risk Ratio Analysis.pdf

93.8 KB

Robust Analysis for Crossover Design.pdf

597.0 KB

ROC Curve.pdf

670.0 KB

Sample Size Calculation Based on Nonparametric Statistics.pdf

381.3 KB

Sample Size Calculation for Survival Data.pdf

308.8 KB

Sample Size Determination.pdf

673.3 KB

Sample Size Re-estimation Based on Observed Treatment Difference.pdf

218.2 KB

Screening Design.pdf

61.3 KB

Selection of Control in Clinical Trials.pdf

249.3 KB

Sequential Estimation for the Additive Hazards Rate Model with Staggered Entry.pdf

89.1 KB

Slope Approach for Assessment of Dose Proportionality-Linearity Under a Crossover Design.pdf

658.8 KB

Spatio-Temporal Modeling.pdf

566.9 KB

Specifications.pdf

99.3 KB

SROC Curve.pdf

196.9 KB

Stability Analysis for Frozen Drug Products.pdf

222.8 KB

Stability Matrix Designs.pdf

248.2 KB

Statistical Principles for Clinical Trials.pdf

207.8 KB

Statistical Process Control.pdf

818.4 KB

Statistical Significance.pdf

227.8 KB

Statistical Tests for Biomarker Development with Applications to Genetics Data.pdf

121.9 KB

Structural Equation Model.pdf

141.0 KB

Stuart-Maxwell Test.pdf

82.4 KB

Subgroup Analysis.pdf

369.0 KB

Subject-Treatment Interaction.pdf

219.5 KB

Survival Analysis.pdf

560.0 KB

Testing for Qualitative Interaction.pdf

113.7 KB

Therapeutic Equivalence.pdf

258.5 KB

Titration Design.pdf

215.4 KB

Toxicological Studies.pdf

591.9 KB

Trend Estimation.pdf

99.8 KB

Two-Stage Design- Phase II Cancer Clinical Trials.pdf

167.8 KB

USP Tests.pdf

92.8 KB

Vaccine Clinical Trials.pdf

727.0 KB

Validation of Quantitative and Qualitative Assays.pdf

1.0 MB

Validity of LOCF.pdf

306.0 KB

Z-Score.pdf

70.7 KB

 

Total files 197


Copyright © 2024 FileMood.com